MCK — McKesson Corporation stock price and chart

MCK

McKesson CorporationStock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.1% · Russell 1000 0.1% · Russell 3000 0.1% · US Stock Market 0.1% · MSCI ACWI 0.1% · MSCI World 0.1%

$881.51+0.07%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

200.0300.0400.0500.0600.0700.0800.0900.0050.0M$881.51

2026-09-11

Price$881.51

MA20$824.52

MA50$813.40

Vol5.1M

What would $1,000 invested in MCK be worth today? →

MCK returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $881.51
Change YTD: +7.79%
Next earnings: Nov 4, 2026
Market cap: 102.8B2016-09 37.7B2026-09 102.7B+172.5% over the window
Enterprise value: 111.3B
Shares outstanding: 116.6M2016-06 225.7M2026-06 116.6M-48.3% over the window
52W low: $687.68
52W high: $999.00
From 52W high: -11.76%
From 52W low: +28.19%
52W range: 62%
Beta: 0.30

Volume

Rel volume: 0.86×
30D volume: 971.9K
30D $ vol: 851.7M

Fundamentals

Sales (ttm): 411B2016-06 193.1B2026-06 411B+112.9% over the window
Sales/share: $3,525.022016-06 $855.422026-06 $3,525.02+312.1% over the window
EPS (ttm): $37.472016-06 $9.622026-06 $37.47+289.5% over the window
FCF (ttm): 6.4B2016-06 4.6B2026-06 6.4B+39.8% over the window
FCF/share: $55.032016-06 $20.342026-06 $55.03+170.6% over the window
Book value/share: -$36.372016-06 $40.982026-06 -$36.37-188.7% over the window
Net margin: 1.12%2016-06 1.2%2026-06 1.1%-3.0% over the window
ROA: 5.20%2016-06 3.8%2026-06 5.2%+35.4% over the window
Current ratio: 0.892016-06 1.072026-06 0.89-16.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.85%2025-06-30 → 2026-06-30377.6B → 411B (+8.8% total)+13.10%2023-06-30 → 2026-06-30284B → 411B (+44.7% total)+10.88%2021-06-30 → 2026-06-30245.2B → 411B (+67.6% total)+7.85%2016-06-30 → 2026-06-30193.1B → 411B (+112.9% total)
Net income: +45.17%2025-06-30 → 2026-06-303.2B → 4.6B (+45.1% total)+6.98%2023-06-30 → 2026-06-303.8B → 4.6B (+22.5% total)n/a+7.52%2016-06-30 → 2026-06-302.2B → 4.6B (+106.5% total)
FCF: +6.85%2025-06-30 → 2026-06-306B → 6.4B (+6.8% total)+11.32%2023-06-30 → 2026-06-304.7B → 6.4B (+37.9% total)+12.82%2021-06-30 → 2026-06-303.5B → 6.4B (+82.8% total)+3.41%2016-06-30 → 2026-06-304.6B → 6.4B (+39.8% total)
Shares: -6.27%2025-06-30 → 2026-06-30124.4M → 116.6M (-6.3% total)-4.75%2023-06-30 → 2026-06-30134.9M → 116.6M (-13.6% total)-5.50%2021-06-30 → 2026-06-30154.7M → 116.6M (-24.6% total)-6.39%2016-06-30 → 2026-06-30225.7M → 116.6M (-48.3% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +50.27%2025-06-30 → 2026-06-30$24.94 → $37.47 (+50.2% total)+11.80%2023-06-30 → 2026-06-30$26.81 → $37.47 (+39.7% total)n/a+14.57%2016-06-30 → 2026-06-30$9.62 → $37.47 (+289.5% total)
Sales/share: +16.13%2025-06-30 → 2026-06-30$3,035.71 → $3,525.02 (+16.1% total)+18.74%2023-06-30 → 2026-06-30$2,105.52 → $3,525.02 (+67.4% total)+17.33%2021-06-30 → 2026-06-30$1,585.41 → $3,525.02 (+122.3% total)+15.21%2016-06-30 → 2026-06-30$855.42 → $3,525.02 (+312.1% total)
FCF/share: +14.00%2025-06-30 → 2026-06-30$48.28 → $55.03 (+14.0% total)+16.86%2023-06-30 → 2026-06-30$34.48 → $55.03 (+59.6% total)+19.39%2021-06-30 → 2026-06-30$22.69 → $55.03 (+142.5% total)+10.47%2016-06-30 → 2026-06-30$20.34 → $55.03 (+170.6% total)
Dividend/share: +15.50%2025-06-30 → 2026-06-30$2.84 → $3.28 (+15.5% total)+14.94%2023-06-30 → 2026-06-30$2.16 → $3.28 (+51.9% total)+14.32%2021-06-30 → 2026-06-30$1.68 → $3.28 (+95.2% total)+11.35%2016-06-30 → 2026-06-30$1.12 → $3.28 (+192.9% total)
Price: +22.48%2025-09-11 → 2026-09-11$719.80 → $881.51 (+22.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+27.63%2023-09-11 → 2026-09-11$423.90 → $881.51 (+108.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+34.16%2021-09-10 → 2026-09-11$202.73 → $881.51 (+334.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+17.47%2016-09-09 → 2026-09-11$176.09 → $881.51 (+400.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +22.97%2025-09-11 → 2026-09-11$716.98 → $881.51 (+22.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+28.20%2023-09-11 → 2026-09-11$418.32 → $881.51 (+110.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+34.85%2021-09-10 → 2026-09-11$197.57 → $881.51 (+346.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+18.36%2016-09-09 → 2026-09-11$163.20 → $881.51 (+440.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 23.5×2016-09 19.702026-09 22.37+13.6% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 15.8×2016-09 11.742026-09 15.82+34.7% over the window
Fwd P/E: 17.6×
P/S (ttm)Market cap ÷ TTM revenue.: 0.3×2016-09 0.192026-09 0.25+28.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: -24.2×2016-09 3.992026-09 -24.23-707.2% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 16.0×2016-09 7.712026-09 16.01+107.6% over the window
EV/EBITDA (fy): 16.4×
EV/Sales (ttm): 0.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.24%2016-06 12.2%2026-06 7.3%-40.2% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.37%
Dividend/share (fwd): $3.28
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 116.6M ÷ 124.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 6.27%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (6.27%) + dividends paid over that year ($393M) ÷ market_cap_at(2025-06-30) ($91.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 6.70%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($6.7B) ÷ today's market cap ($102.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 6.52%2016-06 4.2%2026-06 7.6%+83.2% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $6.7B + TTM dividends $393M) ÷ today's market cap ($102.8B). Same caveat as the cash buyback yield.: 6.90%2016-06 4.8%2026-06 8.1%+67.2% over the window

Vs own 10Y history

P/E: 42nd
P/OI: 41st
P/S: 93rd
P/B: 95th
P/FCF: 85th

Bar = where today’s multiple sits in MCK’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+0.07%

-4.33%

+0.42%

+12.10%

YTD

+7.79%

+25.31%

+337.39%

Financial statements

Open full MCK financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

McKesson Corporation (MCK) trades at $881.51 with a live price and an interactive chart covering 31+ years of daily price history, plus key valuation metrics. ChartRow also publishes MCK’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full MCK financial statements →

MCK — McKesson Corporation price, chart and key statistics